Benzinga

Benzinga

Benzinga

venerdì, agosto 28

Addus HomeCare Corp

ADUSNASDAQ
Trade with Public
Trade with Public
$115.55
-2.46-2.08%
In chiusura: Aug 28, 5:00 PM EST
$115.55
N/A
Post-mercato: 4:00 PM EST
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaOpzioniRapporto azionario

Addus HomeCare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Addus HomeCare (ADUS).

Price Target Range — 12 Quarters

Analyst Consensus — 13 Analysts

2S.Buy
9Buy
1Hold
1Sell
Consensus RatingOverweight# Analysts13Avg. Consensus PT$137Upside to Avg. PT+18.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 5, 2026RBC CapitalBen HendrixPT RaiseOutperform$130→$134
Jul 9, 2026BarclaysAndrew MokPT RaiseUnderweight$92→$96
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
RBC Capital Maintains Outperform on Addus HomeCare, Raises Price Target to $134

RBC Capital analyst Ben Hendrix maintains Addus HomeCare (NASDAQ:ADUS) with a Outperform and raises the price target from $130 to $134.
Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Addus HomeCare, Raises Price Target to $96

Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and raises the price target from $92 to $96.
Benzinga Newsdesk

PRO
Citizens Reiterates Market Outperform on Addus HomeCare, Maintains $142 Price Target

Citizens analyst Constantine Davides reiterates Addus HomeCare (NASDAQ:ADUS) with a Market Outperform and maintains $142 price target.
Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Addus HomeCare, Lowers Price Target to $92

Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and lowers the price target from $102 to $92.
Benzinga Newsdesk

PRO
Citizens Maintains Market Outperform on Addus HomeCare, Lowers Price Target to $142

Citizens analyst Constantine Davides maintains Addus HomeCare (NASDAQ:ADUS) with a Market Outperform and lowers the price target from $150 to $142.
Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Addus HomeCare, Lowers Price Target to $102

Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and lowers the price target from $112 to $102.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved